Brain-computer interface (BCI) specialist Synchron has previewed an artificial intelligence model that it believes will form the basis of a new generation of devices to allow individuals to control ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Elon Musk’s Neuralink company has said it has implanted its wireless brain implant device into a human being for the first time, following FDA approval of clinical trials last year. In a series of ...
We haven’t heard much from Synchron since the summer of 2023, but the beginning of 2026 has brought good tidings. The new Sealab Ti300M sports a familiar look, yet it brings modern features ...
Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.
Feb. 6, 2026 Scientists at Keck Medicine of USC are testing an experimental stem cell therapy that aims to restore the brain’s ability to produce dopamine, the chemical whose loss drives Parkinson’s ...
Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience. To access our Live RNS you must confirm you are a private investor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results